The “face” of the patient with atrial fibrillation (AF) who will benefit from some level of anticoagulation therapy is changing. The most recent change in look is a result of updated guidelines put forth by the American Heart Association, American College of Cardiology, and Heart Rhythm Society in 2014.

Which of the following are current guideline recommendations for oral anticoagulation in patients with atrial fibrillation?

A. Use oral anticoagulation in male patients with CHA2DS2-VASc score ≥1 and female patients with a score ≥2.

B. Use oral anticoagulation in CHA2DS2-VASc stroke risk score ≥2 for patients of both sexes.

C. Use oral anticoagulation in CHA2DS2 stroke risk score ≥2 for patients of both sexes.

D. All of the above

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!

Oral Anticoagulation: Would You Recognize a Candidate?

Newsletter